JULIE DREW: Open Payments
NPI 1568520658 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 41 payments from 16 companies in 2025. Trend: 2023 $591 · 2024 $919 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $183 |
| ABBVIE INC. | 4 | $89 |
| PFIZER INC. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Novo Nordisk Inc | 4 | $69 |
| Lilly USA, LLC | 4 | $63 |
| Astellas Pharma US Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| SANOFI PASTEUR INC. | 1 | $25 |
Products named: AIRSUPRA, REXULTI, MOUNJARO, VRAYLAR, Veozah, Wegovy, FARXIGA, CAPLYTA.
Industry payments across NC — which companies pay providers there.
